Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Aurora Spine Corporation (V:ASG)

Business Focus: Medical Equipment, Supplies & Distribution (NEC)

Feb 05, 2024 07:30 am ET
Aurora Spine’s Second Patent Related to DEXA Technology™ Patient-Matched Implant Technology Issued by the United States Patent Office
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the issuance of its second United States Patent No: 11,850,162...
Jan 29, 2024 07:30 am ET
The United States Patent Office Grants New Patent for Aurora Spine’s Translucent GhostTube™ Surgical Operating Tube
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the issuance of its United States Patent No: 11,832,853 entitled...
Jan 18, 2024 07:21 am ET
AURORA SPINE ANNOUNCES ATTENDANCE AT NORTH AMERICAN NEUROMODULATION SOCIETY (NANS) ANNUAL MEETING
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it will be participating in the North...
Jan 08, 2024 07:30 am ET
Aurora Spine Announces Attendance at J.P. Morgan Healthcare Conference
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it will be attending the J.P. Morgan...
Dec 04, 2023 07:00 am ET
Aurora Spine Corporation Announces Newly Published Paper on First 6-month Clinical Evaluation of its ZIP™ Fusion Implant
Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the publication of the first 6-month clinical...
Nov 17, 2023 05:01 pm ET
Aurora Spine Grants Stock Options
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, announces that it has granted options (the "Options") to acquire...
Nov 14, 2023 07:29 pm ET
Aurora Spine Corporation Announces Third Quarter Fiscal 2023 Financial Results
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the financial results for its third quarter...
Nov 13, 2023 05:14 pm ET
Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss Third Quarter Fiscal Year 2023 Financial Results
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced today announced it has scheduled a conference...
Oct 26, 2023 07:54 pm ET
TSX Venture Exchange Stock Maintenance Bulletins
VANCOUVER, BC, Oct. 26, 2023 /CNW/ -
Oct 23, 2023 07:15 am ET
AURORA SPINE ANNOUNCES CLOSING OF PRIVATE PLACEMENT FINANCING
Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSX VENTURE: ASG) (OTCQB: ASAPF) is pleased to announce that it has completed a non-brokered private placement offering of units ("Units") for gross proceeds of approximately CDN$1.9...
Sep 13, 2023 07:15 am ET
Aurora Spine Announces Full Release of its SiLO TFX™ MIS Sacroiliac Joint Fixation System
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, announced today that it is in full commercial release of its...
Aug 28, 2023 07:15 am ET
Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss Second Quarter Fiscal Year 2023 Financial Results
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it has scheduled a conference call to update...
Aug 23, 2023 07:30 am ET
Aurora Spine Corporation Announces Second Quarter Fiscal 2023 Financial Results
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the financial results for its second quarter...
Jun 28, 2023 07:30 am ET
Aurora Spine Announces Initial Patient Enrolled for DEXA-CTM Multicenter Study
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that the first patient has been enrolled for its...
May 24, 2023 07:00 am ET
Aurora Spine Corporation Announces First Quarter Fiscal 2023 Financial Results
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the financial results for its first quarter...
May 23, 2023 07:15 am ET
Aurora Spine Corporation Schedules Release of First Quarter Fiscal Year 2023 Financial Results and Conference Call
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it will issue its financial results press release...
May 01, 2023 11:09 am ET
Correction: Aurora Spine Corporation Announces Fourth Quarter and Fiscal 2022 Financial Results
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES Company reports record annual revenues of $14.9 million, showing 41% growth -Management to host conference call today, May 1, 2023 at 12:00 PM ET - CARLSBAD,...
May 01, 2023 07:15 am ET
Aurora Spine Corporation Announces Fourth Quarter and Fiscal 2022 Financial Results
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the financial results for fiscal 2022 ended...
Apr 26, 2023 01:18 pm ET
Aurora Spine Corporation Schedules Release of Fourth Quarter and Fiscal Year 2022 Financial Results and Conference Call
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it will issue its financial results press release...
Apr 25, 2023 07:50 am ET
Aurora Spine to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023 & 1x1 Meetings on Thursday, April 27, 2023
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it will be presenting at the Planet MicroCap...
Apr 19, 2023 07:30 am ET
Aurora Spine to Attend the American Association of Neurological Surgeons Annual Meeting
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it will be attending the 2023 American...
Apr 17, 2023 07:15 am ET
Aurora Spine Announces Initial Surgeries Conducted Using its SiLO TFX™ MIS Sacroiliac Joint Fixation System
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that initial surgeries using its proprietary SiLO...
Apr 12, 2023 07:00 am ET
Aurora Spine Announces Presentation on DEXA Technology at the American Association of Neurological Surgeons Annual Meeting
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that its DEXA Technology will be highlighted at...
Apr 04, 2023 07:30 am ET
Aurora Spine Receives IRB Multi-Site Selection Approval for its DEXA-C™ Cervical Interbody System
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) (OTCQB:ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it has received Institutional Review Board (IRB)...
Mar 02, 2023 07:15 am ET
Aurora Spine Receives IRB Approval To Commence Multicenter Study for its DEXA-C™ Cervical Interbody System
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it has received Institutional Review Board (IRB)...
Nov 21, 2022 07:15 am ET
Aurora Spine Corporation Announces Third Quarter Fiscal 2022 Financial Results
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the financial results for the third quarter ended...
Nov 15, 2022 07:19 pm ET
Aurora Spine Corporation Schedules Release of Third Quarter Fiscal Year 2022 Financial Results and Conference Call
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it will issue its financial results press release...
Oct 27, 2022 07:15 am ET
Aurora Spine Corporation Announces Positive Interim Results from Clinical Study using ZIP™ MIS Interspinous Fusion System
Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced positive interim results from a clinical study...
Oct 11, 2022 07:15 am ET
Aurora Spine Corporation to Attend the North American Spine Society (NASS) Annual Meeting
Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it will be participating at the 2022 North...
Oct 11, 2022 07:00 am ET
Aurora Spine Receives 2022 Best New Spine Technology Award for its DEXA bone density-matched spine implant innovation
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it is the recipient of the Annual Spine...
Oct 06, 2022 07:15 am ET
Aurora Spine Corporation Announces FDA 510(k) Clearance for its SiLO TFX™ MIS Sacroiliac Joint Fixation System
Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it has received 510(k) clearance from the United...
Oct 04, 2022 05:53 pm ET
Aurora Spine Corporation Announces FDA 510(k) Clearance for its SiLO TFX™ MIS Sacroiliac Joint Fixation System
Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it has received 510(k) clearance from the United...
Sep 20, 2022 10:48 am ET
Aurora Spine Corporation to Participate in the Lytham Partners Fall 2022 Investor Conference
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it will be participating in the Lytham...
Aug 29, 2022 07:15 am ET
Aurora Spine Corporation Announces Record Second Quarter Fiscal 2022 Financial Results
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the financial results for the second quarter...
Aug 22, 2022 07:15 am ET
Aurora Spine Corporation Schedules Release of Second Quarter Fiscal Year 2022 Financial Results and Conference Call
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it will issue its financial results press release...
Jul 12, 2022 07:15 am ET
Aurora Spine Announces New FDA indication clearance of Lumbar Spinal Stenosis for its ZIP™ series of MIS implants
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a manufacturer of innovative spinal implants, today announced the FDA clearance of a new Lumbar Spinal Stenosis Indication for Use for its ZIP™ family of MIS...
Jun 13, 2022 07:15 am ET
Aurora Spine Corporation Issued Patent by USPTO For Its Interlaminar Single Implant Technology For Motion Preservation or Fusion
Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the issuance of United States Patent No:...
Jun 06, 2022 07:15 am ET
Aurora Spine Corporation Receives FDA 510(k) Clearance for DEXA SOLO-LTM Anterior Lumbar Interbody Fusion Device as part of its DEXA Technology Platform
Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it had received FDA 510(k) clearance for its...
May 24, 2022 07:15 am ET
Aurora Spine Corporation Announces Record First Quarter Fiscal 2022 Financial Results
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the financial results for the first quarter ended...
May 23, 2022 07:15 am ET
Aurora Spine Corporation Schedules Release for First Quarter Fiscal Year 2022 Financial Results and Conference Call
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it will issue its financial results press release...
Apr 29, 2022 09:00 pm ET
Correction: Aurora Spine Corporation Announces Fourth Quarter and Fiscal 2021 Financial Results
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the financial results for the fourth quarter and...
Apr 29, 2022 07:03 pm ET
Aurora Spine Corporation Announces Fourth Quarter and Fiscal 2021 Financial Results
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES Company reports strong revenue growth of 22% in Q4 and expects sequential increase in revenues for Q1 2022 -Management to host conference call on Monday, May 2, 2022...
Apr 28, 2022 07:00 am ET
Aurora Spine Corporation Schedules Release for Fourth Quarter and Fiscal Year 2021 Financial Results and Conference Call
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it will issue its financial results press release...
Mar 31, 2022 07:00 am ET
Aurora Spine Corporation to Participate in the Lytham Partners Spring 2022 Investor Conference
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a manufacturer of innovative spinal implants, announced today that it will be participating in the Lytham Partners Spring 2022 Investor Conference taking place...
Mar 03, 2022 07:00 am ET
Aurora Spine Corporation Announces Initial Implantation of the World’s First Bone Density Matched DEXA-C Cervical Interbody Fusion Device
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a manufacturer of innovative spinal implants announced today that it has completed the world’s first DEXA-C implantation at Cypress Pointe Surgical Hospital in...
Feb 24, 2022 07:15 am ET
Aurora Spine Corporation Announces Co-Marketing Agreement for its DEXA Platform with Echolight Medical
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a manufacturer of innovative spinal implants announced today that it has entered into a joint co-marketing agreement with Echolight Medical, a manufacturer of...
Feb 22, 2022 07:15 am ET
Aurora Spine Corporation Announces Preliminary Revenue for Fourth Quarter and Fiscal 2021
Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced a business update for investors and preliminary,...
Feb 07, 2022 07:15 am ET
Aurora Spine Receives “Notice of Allowance” for Patent for Spinal Implant for Motion Preservation or Fusion
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, announced today that it has received “Notice of Allowance” for...
Jan 25, 2022 07:15 am ET
Aurora Spine Announces Initial Surgeries Using its Proprietary APOLLOTM Cervical Plate
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, announced today that the first anterior cervical discectomy and...
Dec 21, 2021 07:00 am ET
Aurora Spine Corporation Announces Newly Published Paper on Need for a Bone Mineral Density-Matched Interbody Cage
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, announced today that a Peer-Reviewed Clinical Publication titled...
Dec 07, 2021 07:15 am ET
Aurora Spine Corporation to Participate in the Lytham Partners Winter 2021 Investor Conference
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, announced today that it will be participating in the Lytham...
Dec 02, 2021 07:15 am ET
Aurora Spine Corporation Retains PRIA Healthcare to Improve Patient Access to Proprietary Products
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it has retained PRIA Healthcare to assist in...
Nov 16, 2021 07:15 am ET
Aurora Spine Corporation Announces Third Quarter 2021 Financial Results
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the financial results for the third quarter ended...
Nov 11, 2021 07:30 pm ET
Aurora Spine Corporation Schedules Release for Third Quarter 2021 Financial Results and Webcast Call
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it will issue its financial results press release...
Sep 30, 2021 08:25 pm ET
Aurora Spine Corporation to Present at the Lytham Partners Fall 2021 Investor Conference
Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it will participate in the Lytham Partners Fall...
Sep 27, 2021 07:15 am ET
Aurora Spine Corporation Announces Participation at the North American Spine Society Annual Meeting
Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it would be participating at the 2021 North...
Sep 20, 2021 10:13 am ET
Aurora Spine Corporation Announces Closing of C$6.5 Million Private Placement with Institutional Investors
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it has closed its previously announced...
Sep 15, 2021 09:25 am ET
Aurora Spine Corporation Announces C$6.5 Million Private Placement with Institutional Investors
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it has entered into securities purchase...
Aug 26, 2021 07:15 am ET
Aurora Spine Corporation Announces Second Quarter 2021 Financial Results
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the financial results for the second quarter...
Aug 10, 2021 07:15 am ET
Aurora Spine Corporation Announces First Patients in Multicenter Study of ZIP® Interspinous Fixation Device
Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that the first patients have been enrolled into a...
Aug 03, 2021 07:15 am ET
Aurora Spine Corporation Announces FDA 510(k) Clearance for DEXA-C™ Cervical Interbody System
Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it had received U.S. Food and Drug Administration...
Jul 28, 2021 07:15 am ET
Aurora Spine Corporation to Participate in Alliance Global Partners Virtual MedTech Summer Conference
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced its management team will be participating in...
Jul 21, 2021 07:15 am ET
Aurora Spine Corporation to Attend Third Annual American Society of Pain & Neuroscience Conference
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it will be participating in the Third Annual ASPN...
Jun 08, 2021 07:15 am ET
Aurora Spine Corporation to Present at the Lytham Partners Summer 2021 Investor Conference
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it will participate in the Lytham Partners...
May 27, 2021 06:55 am ET
Aurora Spine Corporation Reports First Quarter 2021 Financial Results
Aurora Spine Corporation (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced financial results for the three-months ended March 31, 2021. All figures are in US...
May 06, 2021 08:15 am ET
Aurora Spine receives IRB approval to commence registration for Multicenter Study of its SiLO™ Device for SI Joint Pain
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it has received Institutional Review Board...
Apr 30, 2021 10:09 pm ET
Aurora Spine Corporation Announces Fourth Quarter and Fiscal 2020 Financial Results
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the financial results for the fourth quarter and...
Mar 29, 2021 07:30 am ET
Aurora Spine receives IRB approval for Multicenter Study of its ZIP® Interspinous Fixation Device for Relief of Back Pain
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it has received Institutional Review Board...
Mar 25, 2021 07:30 am ET
Aurora Spine Receives FDA 510(K) Clearance for Its Proprietary APOLLO Anterior Cervical Plate
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, announced today that it has received U.S. Food and Drug...
Mar 17, 2021 08:00 am ET
Aurora Spine to Present at Lytham Partners Spring 2021 Investor Conference
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it will present at the Lytham Partners...
Mar 01, 2021 07:00 am ET
Aurora Spine Corporation Announces Successful Launch of its Proprietary SiLO™ Posterior SI Joint Fusion System
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it has successfully launched its proprietary...
Feb 24, 2021 08:15 am ET
Aurora Spine Announces Receipt of Loan Proceeds Under Paycheck Protection Program
Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSX VENTURE:ASG) (OTCQB:ASAPF) announced today that it has received loan proceeds of $350,140 (“PPP Loan”) under the Second Draw Paycheck Protection Program. The Paycheck Protection...
Feb 09, 2021 12:36 pm ET
Aurora Spine Announces Listing of Shares to OTCQB Exchange
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that its common shares are now trading on the...
Dec 17, 2020 04:01 pm ET
Aurora Spine Plans A Major Multicenter Study of its ZIP™ Interspinous Fixation Device for Relief of Back Pain
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG), a designer and manufacturer of innovative medical devices, today announced plans to commence a multicenter study of its ZIP™ Interspinous Fixation device for patients suffering...
Nov 30, 2020 08:00 am ET
Aurora Spine Announces New Pain Care Division
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it has created a new Pain Care Division focused on the rapidly...
Nov 19, 2020 06:50 pm ET
Aurora Spine Corporation Announces Financial Results for Third Quarter
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (US: AROSF), a company focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant...
Nov 02, 2020 10:02 pm ET
Aurora Spine Announces Commercial Launch of The SOLO™ System
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it has commercially launched its proprietary SOLOTM ALIF...
Oct 05, 2020 07:48 pm ET
Aurora Spine’s Patent Related to DEXA Technology™ Patient-Matched Implant Technology Issued by the United States Patent Office
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the issuance of its United States Patent No: 10,779,954 entitled...
Oct 01, 2020 05:17 pm ET
Aurora Spine Corporation to Present at the October 2020 Lytham Partners Virtual Investor Growth Conference
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) is scheduled to participate in a virtual presentation and fireside chat at the October 2020 Lytham Partners Virtual Investor Growth Conference on Thursday, October 8, 2020 at...
Aug 31, 2020 08:00 am ET
Aurora Spine Corporation Announces Financial Results for Second Quarter
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (US: AROSF), a company focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant...
Aug 18, 2020 05:21 pm ET
Aurora Spine Receives “Notice of Allowance” for Patent: DEXA Technology™ —The World’s First Patient-Matched Interbody Implant Technology to Enable Improved Spine Surgery
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) today announced it has received “Notice of Allowance” for its patent from the United States Patent and Trademark Office (USPTO) for Patient-Matched Interbody Implant Technology....
Aug 12, 2020 08:30 am ET
Aurora Spine Corporation to Present at the August 2020 Lytham Partners Virtual Investor Growth Conference
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) is scheduled to participate in a virtual presentation and fireside chat at the August 2020 Lytham Partners Virtual Investor Growth Conference on Wednesday, August 19, 2020 at...
Jul 09, 2020 08:47 pm ET
Aurora Spine Corporation Files Condensed Consolidated Financial Statements for the Three Months Ended March 31, 2020
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) announces financial results for the First Quarter 2020, ended March 31, 2020.  All figures are in U.S. dollars. To our Shareholders: Q1 2020 started strongly for the...
Jul 02, 2020 08:00 pm ET
Aurora Spine Announces New Chief Financial Officer
Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSX VENTURE:ASG) announced the promotion of Chad Clouse to the position of Chief Financial Officer (CFO), effective July 2, 2020. Mr. Clouse graduated from Pennsylvania State University...
Jun 26, 2020 06:17 pm ET
Aurora Spine Quarterly Filings Update
Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSX VENTURE:ASG) is providing an update on the status of the filing of its quarterly financial statements and accompanying management’s discussion and analysis, and related CEO and CFO...
Jun 18, 2020 08:30 am ET
Aurora Spine Corporation to Present at June 2020 Lytham Partners Virtual Investor Growth Conference
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) is scheduled to participate in a virtual presentation and fireside chat at the June 2020 Lytham Partners Virtual Investor Growth Conference on Wednesday, June 24, 2020 at 5:00pm...
Jun 17, 2020 08:00 pm ET
Aurora Spine Postpones and Reschedules Annual Meeting of Shareholders
Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSX VENTURE:ASG) announced today that given the extraordinary circumstances of the ongoing COVID-19 pandemic and the resulting restrictions on public gatherings, it is postponing its...
Jun 04, 2020 08:21 pm ET
Aurora Spine Corporation Announces 2019 Year End Results
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) announces financial results for the year ended December 31, 2019. To our Shareholders:2019 was a record year for Aurora Spine recording the highest revenue in the Company’s...
May 26, 2020 08:00 pm ET
Aurora Spine Annual Filings Update
Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSX VENTURE:ASG) is providing an update on the status of the filing of its annual financial statements and accompanying management’s discussion and analysis, and related CEO and CFO...
May 14, 2020 08:00 pm ET
Aurora Spine Quarterly Filings Update
Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSX VENTURE:ASG) is providing an update on the status of the filing of its quarterly financial statements and accompanying management’s discussion and analysis, and related CEO and CFO...
Apr 27, 2020 07:30 pm ET
Aurora Spine Announces Receipt of Loan Proceeds Under Paycheck Protection Program
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSX VENTURE:ASG) announced today that it has received loan proceeds of $450,877 (“PPP Loan”) under the Paycheck Protection Program (“PPP”). The PPP was established as part of the...
Apr 16, 2020 07:30 pm ET
Aurora Spine Annual Filings Update
Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSX VENTURE:ASG) is providing an update on the status of the filing of its annual financial statements and accompanying management’s discussion and analysis, and related CEO and CFO...
Feb 07, 2020 08:30 am ET
Aurora Spine Announces Closing of Private Placement Financing
Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSX VENTURE:ASG) is pleased to announce that it has closed the final tranche of its non-brokered private placement offering (the "Offering"). Under the final tranche of the Offering, the...
Feb 03, 2020 08:30 am ET
Aurora Spine Announces Closing of First Tranche of Private Placement Financing
Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSX VENTURE:ASG) is pleased to announce that it has closed the first tranche of up to approximately CDN$2.2 million non-brokered private placement offering (the "Offering"). Under the...
Dec 17, 2019 04:42 pm ET
Aurora Spine Announces New Chief Financial Officer
Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSX VENTURE:ASG) announced the appointment of Jana F. Kiena as their Chief Financial Officer (CFO), effective December 17, 2019. Ms. Kiena will help guide and oversee the company's...
Nov 22, 2019 08:30 am ET
Aurora Spine Corporation Reports Record Q1 Revenue, Files Condensed Interim Consolidated Financial Statements for the Three and Nine Months Ended September 30, 2019
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) announces financial results for the three and nine months ended September 30, 2019. To our Shareholders: Q3 2019 was a watershed quarter for the Company and served to sharpen...
Aug 22, 2019 08:30 am ET
Aurora Spine Corporation Reports Record Q2 Revenue; Files Condensed Interim Consolidated Financial Statements for the Three and Six Months Ended June 30, 2019
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) announces financial results for the three and six months ended June 30, 2019. To our Shareholders:Q2 2019 was a strong quarter for the Company based on several financial...
May 30, 2019 05:26 pm ET
Aurora Spine Corporation Reports Record Q1 Revenue; Files Condensed Interim Consolidated Financial Statements For the Three Months Ended March 31, 2019
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) announces financial results for the three months ended March 31, 2019. To our Shareholders: Q1 2019 was a strong quarter for the Company based on several financial metrics...
Apr 26, 2019 04:59 pm ET
Aurora Spine Corporation Announces 2018 Year End Results
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) announces financial results for the year ended December 31, 2018. To our Shareholders:2018 was a record year for Aurora Spine recording the highest revenue in the Company’s...
Jan 23, 2019 08:30 am ET
Aurora Spine Announces New Patent for Its Minimally Invasive Spinal Implants Allowed by the United States Patent Office
Aurora Spine Corporation (TSXV: ASG) announced today the issuance by the United States Patent and Trademark Office (USPTO) of United States Patent No. 10,143,501 entitled “Expendable Interspinous Device”.  This new patent relates to Aurora’s family...
Nov 22, 2018 07:00 am ET
Aurora Spine Corporation Files Condensed Consolidated Financial Statements for the Three and Nine Months Ended September 30, 2018
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) announces financial results for the Third Quarter, 2018. All figures are in U.S. dollars. To our Shareholders: The third quarter of 2018 was an outstanding quarter. We...
Nov 16, 2018 08:30 am ET
Aurora Spine Announces Exclusive Patent License Agreement for MIS SI Joint Product
Aurora Spine Corporation (TSXV:ASG) ("Aurora Spine" or the "Company") announced today that it has acquired an exclusive license to US patent #9,451,986 titled “Percutaneous sacroiliac joint implant and method for surgically inserting and securing...
Oct 25, 2018 07:00 am ET
Aurora Spine Announces European Patent Related To ZIP Minimally Invasive Spinal Implant
Aurora Spine Corporation (TSXV:ASG) ("Aurora Spine" or the "Company") announced today the grant by the European Patent Office (the “EPO”) of Aurora’s first European patent related to the ZIP®, minimally invasive spinal implant. The patent is titled...
Sep 26, 2018 07:00 am ET
Aurora Spine Participating at North American Spine Society Annual Meeting
Aurora Spine Corporation (TSXV: ASG) announced today that it will be participating at the 2018 North American Spine Society ("NASS") Annual Meeting, September 26-29, 2018 at the Los Angeles Convention Center, Los Angeles, California at Booth 1625....
Aug 27, 2018 07:00 am ET
Aurora Spine Corporation Files Condensed Consolidated Financial Statements for the Three and Six Months Ended June 30, 2018
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) announces financial results for the Second Quarter, 2018. All figures are in U.S. dollars. To our Shareholders: The second quarter of 2018 was an outstanding quarter. We...
Jul 09, 2018 09:01 am ET
100th Surgical Implantation of ZIP ULTRA™ MIS Interspinous Device Performed in Canada
Aurora Spine Corporation (TSXV:ASG) ("Aurora Spine" or the "Company") announced today the 100th surgical implantation of the company's ZIP ULTRA® minimally invasive interspinous device in Canada. These surgeries are part of Aurora Spine's...
May 28, 2018 09:01 am ET
Aurora Spine Corporation Files Condensed Consolidated Financial Statements for the Three Months Ended March 31, 2018
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) announces financial results for the three months ended March 31, 2018. To our Shareholders: Q1 2018 was the best quarter in the Company’s history based on several financial...
Apr 27, 2018 04:01 pm ET
Aurora Spine Corporation Announces 2017 Year End Results
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES
Feb 09, 2018 04:58 pm ET
Aurora Spine Completes Private Placement
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.
Feb 05, 2018 06:22 pm ET
Correction from source: Aurora Spine Announces Upsizing of Private Placement
CARLSBAD, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (TSX-V:ASG) ("Aurora Spine" or the "Company") is pleased to announce that, as a result of strong investor demand, it has increased the size of its previously announced...
Feb 05, 2018 05:53 pm ET
Aurora Spine Announces Upsizing of Private Placement
CARLSBAD, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) --
Jan 11, 2018 09:01 am ET
Aurora Spine Announces Non-Brokered Private Placement
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.
Nov 28, 2017 07:00 am ET
Oct 23, 2017 05:13 pm ET
EARLY WARNING PRESS RELEASE - Purchase of Shares of Aurora Spine Corporation (TSXV: ASG)
TORONTO, Ontario, Oct. 23, 2017 (GLOBE NEWSWIRE) -- David Rosenkrantz of Etobicoke, Ontario and Chairman of the Board of Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) announces the filing of an early warning report in connection with a non-brokered private placement of the Company (the “Offering”)....
Oct 23, 2017 04:01 pm ET
Aurora Spine Corporation Announces Completion of Non-Brokered Private Placement and Filing of Early Warning Report
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES...
May 31, 2017 09:01 am ET
Aurora Spine Offers Its Patented Polyaxial ZIP® ISP Technology for Out-Licensing Opportunities
Aurora Spine Corporation (TSX VENTURE: ASG) announced today that the company has selected its proprietary implant locking technology covered by United States Patent No.: 9,603,637 entitled "POLYAXIAL INTERSPINOUS FUSION IMPLANT AND BONE GROWTH STIMULATION SYSTEM" for out-licensing opportunities for medical and industrial applications.
May 31, 2017 08:59 am ET
Aurora Spine Offers Its Patented Polyaxial ZIP® ISP Technology for Out-Licensing Opportunities
Aurora Spine Corporation (TSX VENTURE:ASG) announced today that the company has selected its proprietary implant locking technology covered by United States Patent No.: 9,603,637 entitled "POLYAXIAL INTERSPINOUS FUSION IMPLANT AND BONE GROWTH...
May 29, 2017 08:59 am ET
Aurora Spine Corporation Files Condensed Consolidated Financial Statements for the Three Months Ended March 31, 2017
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSX VENTURE:ASG) announces financial results for the three months ended March 31, 2017. To...
Apr 27, 2017 08:58 am ET
Aurora Spine Corporation Announces 2016 Year End Results
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSX VENTURE:ASG) announces financial results for the year ended December 31, 2016. To our...
Apr 12, 2017 09:01 am ET
Aurora Spine's Patent Related to its Polyaxial ZIP® ISP Issued by the United States Patent Office
Aurora Spine Corporation (TSX VENTURE: ASG) ("Aurora" or "Aurora Spine") announced today the issuance of its United States Patent No.: 9,603,637 entitled "POLYAXIAL INTERSPINOUS FUSION IMPLANT AND BONE GROWTH STIMULATION SYSTEM." In addition to Aurora's implant family of ZIP(R) ISPs, including its ZIP Ultra(R), ZIP 51(TM), ZIP LP(TM), Dyna-ZIP(TM) and ZIP-Flex, this patent application covers the company's first polyaxial implant design.
Apr 12, 2017 08:59 am ET
Aurora Spine's Patent Related to its Polyaxial ZIP® ISP Issued by the United States Patent Office
Aurora Spine Corporation (TSX VENTURE:ASG) ("Aurora" or "Aurora Spine") announced today the issuance of its United States Patent No.: 9,603,637 entitled "POLYAXIAL INTERSPINOUS FUSION IMPLANT AND BONE GROWTH STIMULATION SYSTEM." In addition to...
Apr 06, 2017 04:28 pm ET
Aurora Spine Corporation Announces Completion of Non-Brokered Private Placement and Filing of Early Warning Report
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSX VENTURE:ASG) is pleased to announce that it has completed a non-brokered...
Jan 25, 2017 09:01 am ET
Aurora Spine Announces New Chief Financial Officer
Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSX VENTURE: ASG) announced the appointment of Sarina Mason as their Chief Financial Officer (CFO), effective February 6, 2017.
Jan 25, 2017 08:59 am ET
Aurora Spine Announces New Chief Financial Officer
Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSX VENTURE:ASG) announced the appointment of Sarina Mason as their Chief Financial Officer (CFO), effective February 6, 2017. Ms. Mason will help guide and oversee the...
Dec 05, 2016 08:25 am ET
Aurora Spine Launches Mobile App
Aurora Spine Corporation (TSX VENTURE:ASG) announced today the launch of its new Aurora Spine Mobile App, designed to bring information regarding the new and exciting products being offered by Aurora Spine straight to your mobile device. The App is...
Dec 05, 2016 08:24 am ET
Aurora Spine Launches Mobile App
Aurora Spine Corporation (TSX VENTURE: ASG) announced today the launch of its new Aurora Spine Mobile App, designed to bring information regarding the new and exciting products being offered by Aurora Spine straight to your mobile device. The App is currently available for Apple, Android, and iPad devices.
Nov 29, 2016 04:28 pm ET
Aurora Spine Corporation Files Condensed Consolidated Financial Statements for the Three Months and Nine Months Ended September 30, 2016
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSX VENTURE:ASG) announces financial results for the three months and nine months ended September 30,...
Oct 25, 2016 09:01 am ET
Aurora Spine Participating at North American Spine Society Annual Meeting
Aurora Spine Corporation (TSX VENTURE: ASG) announced today that it will be participating at the 2016 North American Spine Society ("NASS") Annual Meeting, October 26 - 28, 2016 at the Boston Convention and Exhibition Center Boston, Massachusetts at Booth 1302. The North American Spine Society is a global multidisciplinary medical society that utilizes education, research and advocacy to foster the highest quality, ethical, value and evidence based spine care.
Oct 25, 2016 08:59 am ET
Aurora Spine Participating at North American Spine Society Annual Meeting
Aurora Spine Corporation (TSX VENTURE:ASG) announced today that it will be participating at the 2016 North American Spine Society ("NASS") Annual Meeting, October 26 - 28, 2016 at the Boston Convention and Exhibition Center Boston,...
Aug 26, 2016 06:53 pm ET
Aurora Spine Corporation Files Condensed Consolidated Financial Statements for the 3 Months and Six Months Ended June 30, 2016
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSX VENTURE:ASG) announces financial results for the three months and six months ended June 30, 2016....
Jul 13, 2016 09:01 am ET
Aurora Spine Joins MetroConnect Program to Expand International Growth
Aurora Spine Corporation (TSX VENTURE: ASG) announced today that it has been selected to take part in the MetroConnect Program, a comprehensive export support program run by the World Trade Center San Diego and designed to help San Diego companies accelerate their global growth. The announcement was made on June 30th by San Diego Mayor Kevin Faulconer and World Trade Center San Diego.
Jul 13, 2016 08:59 am ET
Aurora Spine Joins MetroConnect Program to Expand International Growth
Aurora Spine Corporation (TSX VENTURE:ASG) announced today that it has been selected to take part in the MetroConnect Program, a comprehensive export support program run by the World Trade Center San Diego and designed to help San Diego companies...
Jul 05, 2016 04:55 pm ET
Aurora Spine Corporation Announces Loan From Insider
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSX VENTURE:ASG) is pleased to announce that it has received a loan (the "Loan")...
Jun 29, 2016 04:03 pm ET
Aurora Spine Corporation Grants Stock Options
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSX VENTURE:ASG) announces that it has granted options (the "Options") to acquire...
Jun 29, 2016 04:02 pm ET
Aurora Spine Corporation Grants Stock Options
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Jun 22, 2016 08:30 am ET
Aurora Spine's Patent Related to Its ZIP(R) MIS ISP Issued by the United States Patent Office
Aurora Spine Corporation (TSX VENTURE: ASG) announced today the issuance of its United States Patent No.: 9,364,264 entitled "Dynamic and Non-Dynamic Interspinous Fusion Implant and Bone Growth Stimulation System". This patent covers Aurora's family of ZIP(R) ISPs, including its ZIP Ultra(R), ZIP 51(TM), ZIP LP(TM) and Dyna-ZIP(TM) among others.
Jun 22, 2016 08:30 am ET
Aurora Spine’s Patent Related to Its ZIP® MIS ISP Issued by the United States Patent Office
CARLSBAD, Calif., June 22, 2016 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (TSXV:ASG) announced today the issuance of its United States Patent No.: 9,364,264 entitled “Dynamic and Non-Dynamic Interspinous Fusion Implant and Bone Growth Stimulation System”.  This patent covers Aurora’s family of ZIP® ISPs, including its ZIP Ultra®, ZIP 51™, ZIP LP™ and Dyna-ZIP™ among others....
Jun 22, 2016 08:28 am ET
Aurora Spine's Patent Related to Its ZIP(R) MIS ISP Issued by the United States Patent Office
Aurora Spine Corporation (TSX VENTURE:ASG) announced today the issuance of its United States Patent No.: 9,364,264 entitled "Dynamic and Non-Dynamic Interspinous Fusion Implant and Bone Growth Stimulation System". This patent covers Aurora's...
May 31, 2016 08:28 am ET
Aurora Spine Corporation Announces Completion of Non-Brokered Private Placement
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSX VENTURE:ASG) is pleased to announce that it has completed a non-brokered...
May 30, 2016 06:58 am ET
Aurora Spine Corporation Files Condensed Consolidated Financial Statements for the Three Months Ended March 31, 2016
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSX VENTURE:ASG) announces financial results for the three months ended March 31, 2016. To...
Apr 22, 2016 08:29 pm ET
Aurora Spine Corporation Announces 2015 Year End Results
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSX VENTURE:ASG) announces financial results for the year ended December 31, 2015. To our...
Apr 14, 2016 09:25 am ET
Aurora Spine's Patent Related to Its ZIP® ISP Allowed by the United States Patent Office
Aurora Spine Corporation (TSX VENTURE: ASG) announced today the allowance by the United States Patent and Trademark Office of United States Patent Application Serial No. 13/865,155 entitled "Dynamic and Non-Dynamic Interspinous Fusion Implant and Bone Growth Stimulation System". This patent covers Aurora's family of ZIP(R) ISPs, including its ZIP Ultra(R), ZIP 51(TM), ZIP LP(TM) and Dyna-ZIP(TM) among others.